Author

Junsoo Park

Korea Research Institute of Bioscience and BiotechnologyPrimary ORCID profile (0000-0002-2355-6760 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Junsoo ParkiD1 paper · Ottawa Hospital Research Institute

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Eui‐Jeon WooiD· 1 shared J Y KangiD· 1 shared Jae-Rin Kim· 1 shared Jae‐Joong KimiD· 1 shared Juyeon JungiD· 1 shared K S Park· 1 shared Min-Jung Son· 1 shared S H Lee· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Eui‐Jeon WooORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

AI-Driven Design of Nanobinders Targeting the TSLPR Heterodimer Interface to Suppress Type 2 Inflammatory Signaling

Woo‐Chan Ahn, Min-Jung Son, Jae-Rin Kim, Seong-Ryeong Go, J Y Kang, Junsoo Park, Younghoon Lee, S H Lee, Jae‐Joong Kim, Juyeon Jung, Eui‐Jeon Woo, Young‐Joo Jeon, K S Park

This paper designs AI-driven nanobinders targeting the TSLPR-IL-7R heterodimer interface to suppress type 2 inflammatory signaling, showing that geometric mimicry of the native cytokine is more effective than affinity alone.

bioRxiv · Jul 22, 2026 · PreprintBiochemistry